XPRIZE Healthspan Finalist
XPRIZE HEALTHSPAN · 2026

From Over 600 Teams Worldwide
to Milestone 2.

Tokyo Relife Clinic, as a member of the Goda Lab research team, has advanced to Milestone 2,
one of the finalist stages of XPRIZE Healthspan, among more than 600 teams from around the world.

Basic Research — Animal Studies — Clinical Research Protocol

SCROLL
01 / ANNOUNCEMENTTOKYO · JAPAN
02WHAT IS XPRIZE HEALTHSPAN

What is XPRIZE Healthspan？

～Taking on the Universal Challenge of Human Healthspan～

XPRIZE Healthspan is a seven-year international competition dedicated to extending human healthspan.

The competition focuses on age-related changes in physical, cognitive, and immune function. Research teams from around the world are developing new approaches to slow or reverse age-related functional decline and extend the number of years people can live in good health.

Through multiple stages of evaluation, the prize aims to translate advances in healthspan research into real-world impact, making it one of the world's largest competitions focused on medical innovation.

Competition Period
7years
Participating Teams
600+teams
Participating Countries
58countries
Total Prize Purse
$101MUSD
Grand Prize
2030
Current Standing
Milestone2FINALISTS
03THE JOURNEY

Our Challenge to the World,
Now Moving to the Next Stage.

2023Competition Start

XPRIZE Healthspan launches, bringing together research teams from around the world to take on the challenge of extending human healthspan.

2025Milestone 1

The Goda Lab team advances to Milestone 1.

2026Milestone 2 Finalists

The Goda Lab research team is selected as one of the 10 Milestone 2 finalists, among more than 600 teams from around the world.

CURRENT MILESTONE
2030Grand Prize

Final evaluation and Grand Prize announcement scheduled for 2030.

04GODA LAB × TOKYO RELIFE CLINIC

What is Goda Lab？

A Collaborative Team Taking on XPRIZE Healthspan: Goda Lab (The University of Tokyo) × Goda Lab (Tohoku University) × Nano Titan × Tokyo Relife Clinic

Goda Lab team — XPRIZE Healthspan Finalist Award Ceremony
XPRIZE Healthspan Finalist Award Ceremony · 2026

This collaboration began with the establishment of the Endowed Chair on Cellular Senescence Control by the Goda Laboratory and Yoshiaki Furuyama, CEO of Tokyo Relife Clinic.

By building on basic research and bringing together complementary areas of expertise, the collaboration aims to turn cellular senescence control into a reality.

Goda Laboratory

Basic Research & Animal Studies

Through research in areas such as intercellular communication and regenerative biology, we explore new approaches to age-related functional decline and healthspan extension.

TOKYO RELIFE CLINIC

A Regenerative Medicine Clinic Advancing Longevity

Tokyo Relife Clinic integrates research and clinical practice to provide advanced regenerative medicine based on scientific evidence and cellular-level data, in collaboration with research institutions in Japan and around the world.

05HOW WE BECAME FINALISTS

One of 10 Milestone 2 Finalists
Among 600+ Teams.

Over 600 teams from 58 countries competed in XPRIZE Healthspan. Led by Professor Keisuke Goda, the Goda Lab team advanced through multiple evaluation stages by leveraging technologies cultivated through basic research and a research plan designed for future clinical implementation.

Following their success in Milestone 1, the team was selected in 2026 as one of the 10 finalists for Milestone 2.

“ Bridging Research and the Future of Healthspan. ”

06TOKYO RELIFE CLINIC'S VISION

Bringing Advanced Technologies to
Clinical Practice.

At Tokyo Relife Clinic, we strive to lead the way in establishing a continuous cycle between research and clinical practice.

I

From Research to Clinical Practice.

Rather than immediately translating findings from basic research into treatments, we first connect them to clinical research through the necessary assessments and evaluations.

II

From Data to the Next Question.

We use data from clinical research to identify new research questions and refine future research plans.

III

The Cycle of Research and Clinical Practice.

Instead of treating research and clinical practice as a one-way flow, we create a continuous cycle: "from research to clinical practice, and from clinical practice to the next research question."

This is the research-to-clinical cycle Tokyo Relife Clinic aims to achieve through this challenge.

CONTACT

Media & Partnership Inquiries

For inquiries about media coverage, joint research, or partnership opportunities, please contact us using the form below.

Inquiry Type